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Abstract
Background Long-term publicly waitlisted bariatric sur-
gery patients typically experience debilitating physical/
psychosocial obesity-related comorbidities that profoundly
affect their quality of life.
Objectives We sought to measure quality-of-life impacts
in a study population of severely obese patients who had
multiyear waitlist times and then underwent bariatric
surgery.
Methods Participants were recruited opportunistically fol-
lowing a government-funded initiative to provide bariatric
surgery to morbidly obese long-term waitlisted patients.
Participants self-completed the EQ-5D-5L and AQoL-8D
questionnaires pre- and postoperatively. Utility valuations
(utilities) and individual/super dimension scores (AQoL-
8D only) were generated.
Results Participants’ (n = 23) waitlisted time was mean
[standard deviation (SD)] 6.5 (2) years, body mass index
reduced from 49.3 (9.35) kg/m2 preoperatively to 40.8
(7.01) 1 year postoperatively (p = 0.02). One year util-
ities revealed clinical improvements (both instruments).
AQoL-8D improved significantly from baseline to
1 year, with the change twice that of the EQ-5D-5L
[EQ-5D-5L: mean (SD) 0.70 (0.25) to 0.78 (0.25);
AQoL-8D: 0.51 (0.24) to 0.67 (0.23), p = 0.04], despite
the AQoL-8D’s narrower algorithmic range. EQ-5D-5L
utility plateaued from 3 months to 1 year. AQoL-8D
1-year utility improvements were driven by Happiness/
Coping/Self-worth (p\ 0.05), and the Psychosocial
super dimension score almost doubled at 1 year
(p\ 0.05). AQoL-8D revealed a wider dispersion of
individual utilities.
Conclusions Ongoing improvements in psychosocial
parameters from 3 months to 1 year post-surgery
accounted for improvements in overall utilities mea-
sured by the AQoL-8D that were not detected by EQ-
5D-5L. Selection of a sensitive instrument is important
to adequately assess changes in quality of life and to
accurately reflect changes in quality-adjusted life-years
for cost-utility analyses and resource allocation in a
public healthcare resource-constrained environment.
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Key Points for Decision Makers
Psychosocial health status is an important health-
related quality-of-life (HRQoL) outcome for long-
waiting bariatric surgery patients. Whilst the EQ-5D
is prevalent in the economic evaluation of bariatric
surgery, compared with the EQ-5D-5L, the AQoL-
8D preferentially captures and assesses psychosocial
health for this study population.
If used in the clinical setting, utility valuations and
individual and super dimension scores could provide
both clinicians and healthcare decision-makers with
important information regarding HRQoL impacts for
people who have waited many years in the public
health system for their bariatric surgery.
Long-waiting bariatric patients should not be
‘written-off’ by healthcare planners; they can still
realise significant improvements in HRQoL
outcomes when ultimately treated, and this should be
factored into patient prioritisation decisions.
1 Introduction
Obesity is a profoundly complex global public health,
economic, and strategic policy problem [1–5]. Bariatric
(obesity or metabolic) surgery is generally considered the
most efficacious and cost-effective treatment intervention
for people with intractable severe or morbid obesity, par-
ticularly for subgroups of patients such as people with type
2 diabetes [6–13]. Nonetheless, a recent comprehensive
systematic review of 77 diverse health economics studies
that reported on bariatric surgery from 1995 to 2015 found
the EQ-5D is the prevalent multi-attribute utility instru-
ment (MAUI) used in cost-utility analyses of bariatric
surgery worldwide, and the impact of time delay for pub-
licly waitlisted patients on the clinical, quality-of-life, and
economic outcomes of bariatric surgery has been largely
ignored [14].
As an important subgroup of bariatric surgery patients,
long-term morbidly obese, publicly waitlisted, bariatric
surgery patients generally experience increased physical
and psychosocial comorbidity loads that ultimately trans-
late to ‘sicker’ patients demanding proportionally more of
the scarce healthcare dollar [14–17]. Recent qualitative
evidence has indicated that waiting for bariatric surgery
can lead to development of new or worsening obesity-re-
lated comorbidity or decline in mobility and be emotionally
challenging (‘frustrating’, ‘depressing’, ‘stressful’) [18].
Additionally, the need to assess the psychosocial health
status of bariatric patients in the short, medium, and longer
terms has been increasingly identified [19] and recognised
as crucial for bariatric surgery patients [20–24]. Moreover,
the psychosocial health status of bariatric surgery patients
is dynamic, some studies suggesting an improvement up to
4 years and declining thereafter [22, 24]. Other studies
suggest that quality of life significantly improves up to
1 year and is maintained at 2 years [25]. Importantly, there
is a paucity of quantitative evidence concerning the health-
related quality-of-life (HRQoL) impacts for the group of
long-waiting, public healthcare patients who then undergo
bariatric surgery.
Within resource-constrained healthcare budgets, fun-
ders’ perceptions of ‘affordability’ are changing as bar-
iatric surgery has increasingly become accepted as more
than a cosmetic procedure for obesity and as the scale of
the epidemic of severe obesity has become clearer [14].
Furthermore, the allocation of public-sector budgets is one
part of a tremendously complex healthcare landscape that
results in severely obese bariatric surgery candidates (with
complex obesity-related comorbidities that translate to
diminished HRQoL) experiencing multiyear wait times
[14, 15]. A key reason for these multiyear wait times is the
disproportionate rate of increase in severe obesity, and
therefore the ever increasing demand for bariatric surgery
surpassing the relatively static supply [17, 26].
Recent evidence has highlighted the differences and
disagreements regarding the prioritisation of quality-of-life
outcomes by health professionals and patients [27],
revealing that patients prioritised seven quality of life
items, none of which were prioritised by professionals.
Surgeons prioritised only one quality-of-life outcome
(versus four to 11 in the other health professionals’ sub-
groups, e.g. nurses and dieticians) [27]. These findings
highlight the importance of individual, self-reported patient
assessments of HRQoL in the bariatric surgery population.
Standardised outcomes reporting guidelines for meta-
bolic and bariatric surgery were developed by the Ameri-
can Society of Metabolic and Bariatric Surgeons (ASMBS)
to drive consistency of reporting clinical and HRQoL
outcomes within the field [20, 21]. These guidelines
acknowledge that whilst bariatric surgery produces marked
weight loss and improvement of physical comorbidities,
the impact on HRQoL is less well established [20, 21]. The
guidelines did not provide specific recommendations
regarding the reporting of health state utility values, also
described as utility valuations or utilities [24].
Utility valuations are important health economic metrics
that assess the strength of preference for an individual’s
health state relative to perfect health and death, and
importantly have inherent independent meaning [24, 28].
Utilities are assessed relative to a 0.00–1.00 scale, where
1.00 represents perfect health and 0.00 represents death,
and therefore indicates the strength of preference for
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quality versus quantity of life [29]. Utilities are also a vital
component of cost-utility analysis (a commonly used form
of full economic evaluation that assesses the incremental
costs of an intervention versus the incremental gains in
quality-adjusted life-years) [12, 29, 30].
MAUIs are designed to rapidly and simply assess an
individual or study population’s utility valuation(s) through
the application of pre-established formulae/weights to the
array of patient-reported responses to the instrument’s
questions (generally self-reported through, for example,
clinic visits, mail-outs, or the Internet) [24, 31, 32]. Based
on patient-reported responses to MAUIs’ questionnaires,
the algorithm of a given instrument generates utility val-
uations. Many instruments generate utilities that are less
than zero described as a health state perceived to be worse
than death (e.g. the most recent EQ-5D-5L UK value set
range: -0.281 to 1.0 [33, 34]). Most instruments report
minimal clinically important differences or minimal
important differences for their utilities [35–37].
The EQ-5D-5L is an internationally prevalent MAUI
used in the assessment of patient-reported quality-of-life
outcomes and full economic evaluations of treatment
interventions (including bariatric surgery) [14, 38]. Recent
evidence has suggested that for the EQ-5D-3L (precursor to
the 5L), a 1.0-unit decrease in body mass index (BMI) is
associated with a 0.0051- to 0.0075-utility point increase.
For a 1.0-unit decrease in BMI, the study reported a 0.0051
increase in utility when adjusted for baseline presence of
comorbidity (stepwise approach); a 0.0052 increase in
utility when adjusted for age, sex, and baseline BMI; a
0.0068 increase in utility when adjusted for age, sex,
baseline BMI, and baseline comorbidity; and a 0.0075
increase in utility associated with the primary (baseline)
analysis [39].
The AQoL-8D MAUI is informed by psychometric
principles and testing and has been found to preferentially
capture psychosocial health for people who had already
undergone bariatric surgery many years previously in the
private healthcare system {median [interquartile range
(IQR)] 5 (3–8) years} [24, 40, 41]. This study also found
that the AQoL-8D and EQ-5D-5L instruments were not
interchangeable for the study population and that body
weight is just one factor contributing to the complex
HRQoL [24]. A recent study that investigated cross-sec-
tional quality-of-life data using the Moorehead–Ardelt
Quality of Life Questionnaire II also found that quality of
life after bariatric surgery is not just dependent on weight
loss [42]. Nevertheless, the Moorehead–Ardelt Quality of
Life Questionnaire II is not an MAUI.
Another recent study suggested that clear preoperative
predictive markers of well-defined postoperative success
following bariatric surgery would be invaluable and
facilitate a more refined and evidence-based mechanism
by which to select patients for bariatric surgery [43]. The
study found that it is important to explore the relation-
ships between preoperative clinical parameters and
HRQoL in those morbidly obese patients who are eligible
for bariatric surgery, and that identifying those clinical
and psychosocial predictors of success assumes great
significance when selecting (or prioritising) patients for
bariatric surgery [43]. A recent systematic review that
investigated quality-of-life outcomes for bariatric surgery
patients found that the SF-36 was the most commonly
used HRQoL instrument in the review’s 13 included
studies (control group was one of the inclusion criteria)
[25]. Utility valuations were not generated in these studies
[25]. Importantly, utility valuations have been shown to
be independent predictors of patient outcomes in patients
with type 2 diabetes, including all-cause mortality and
development of complications [44]. Clinicians have also
found that measuring utilities is of benefit to patient–
clinical assessment, relationships, communication, and
management [32].
Our study arose from a targeted State Government of
Tasmania, Australia, policy decision to reduce Tasmanian
public hospital surgical waiting lists. This initiative pro-
vided us with a novel and exploratory opportunity to
recruit a cohort of morbidly obese, long-term waitlisted,
bariatric surgery patients who then underwent bariatric
surgery as a result of this policy initiative. This provided
us with the opportunity to investigate an important and
increasingly prevalent study population of bariatric sur-
gery patients who inherently carry complex physical and
psychosocial HRQoL needs. We aimed to investigate the
physical and psychosocial HRQoL changes in these
patients by using the EQ-5D-5L and AQoL-8D MAUIs to
generate utility valuations (both instruments), and the
AQoL-8D’s individual dimensional scores (namely,
Independent Living, Senses, Pain, Happiness, Coping,
Relationships, Self-worth, and Mental Health) and super
dimensional scores (namely, the composite Physical super
dimension of Independent Living, Senses, and Pain; and
the composite Psychosocial super dimension of Happi-
ness, Coping, Relationships, Self-worth, and Mental
Health) preoperatively and at two postoperative time
points (namely, 3 months and 1 year). We also aimed to
explore the HRQoL benefits of bariatric surgery for long-
term waitlisted patients and concomitance with BMI
changes. We further aimed to investigate whether the
MAUIs would reveal significant psychosocial HRQoL
impacts at 1 year postoperatively. We also aimed to
explore whether utility valuations and individual and
super dimension scores could provide healthcare decision-
makers with important information regarding HRQoL
impacts for people who had waited many years in the
public health system for their bariatric surgery.
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2 Methods
2.1 Study Design
2.1.1 Recruitment of Participants
A Tasmanian government policy decision was made in
2014 to allocate additional and targeted public funds to
provide morbidly obese, long-term waitlisted patients with
bariatric surgery in 2015. The policy decision provided us
with an opportunity to recruit bariatric surgery patients
who had waited for their surgery in a public healthcare
system for many years. Appropriate ethics approvals were
obtained from our University’s Health and Medical Human
Research Ethics Committee before commencement of our
study’s recruitment of participants.
We subsequently invited patients who were identified
for bariatric surgery to participate in our study. Participants
were provided an information package and consent mate-
rials before their bariatric surgery pre-admission clinic. The
process for participants’ questionnaire completion after
consenting to participate in the study is outlined in
Sect. 2.1.2.
Participants who consented to participate in our quality-
of-life study underwent publicly funded laparoscopic
adjustable gastric banding (LAGB) surgery by the same
surgeon in the Hobart Private Hospital. Laparoscopic
banding was carried out using Apollo APS or APL bands,
with adjustment ports attached to the left anterior rectus
sheath [45]. Postoperative fluid diets were maintained for
3 weeks, with subsequent transition to normal foods,
accompanied by instruction on eating technique and
exercise.
2.1.2 The Multi-attribute Utility Instruments
and Questionnaire Completion
Our earlier study comparing the EQ-5D-5L and AQoL-8D
MAUIs for people who had undergone LAGB surgery
many years previously provided a detailed summary of the
divergent characteristics of the two purposively selected
MAUIs [24]. Table 1 provides an overview of these char-
acteristics. In summary, the EQ-5D-5L is an internationally
prevalent instrument (e.g. from 2005 to 2010, the EQ-5D
was used in 63% of economic evaluations) [38]; the EQ-5D
instrument is prevalent in the full economic evaluation of
bariatric surgery [14]; it describes 3125 health states
(compared with 243 health states of the EQ-5D-3L pre-
cursor to the 5L); four of the five instrument’s health
domains/classifications focus on physical HRQoL; and it
takes less than 1 min to complete the EQ-5D-5L’s ques-
tionnaire. The EQ-5D-5L also contains a visual analogue
scale (EQ-VAS). In contrast, the AQoL-8D’s classification
system is supported by psychometric principles and testing,
and 25 of the instrument’s 35 items capture and assess five
(from eight) psychosocial domains of health (Happiness,
Table 1 Comparison of the dimensions of the EQ-5D-5L and AQoL-8D multi-attribute utility instruments
Characteristics EQ-5D-5L AQoL-8D
Number of health states
described
3125 2.4 9 1023
Total number of
dimensions
Five dimensions, 1 item in each. Each item has
5 levels of severity scored as 1 (best) to 5
(worst)
Eight dimensions of between 3 and 8 items; 35 items in total. 25 of
the 35 items capture and assess psychosocial domains of health.
Number of dimensions of
physical health
Four dimensions: mobility, self-care, usual
activities, and pain/discomfort
Three dimensions: (1) Independent Living, 4 items (household
tasks, getting around, mobility, self-care); (2) Senses, 3 items
(vision, hearing, communication); and (3) Pain, 3 items
(frequency of pain, degree of pain, pain interference)
Number of dimensions of
psychosocial health
One dimension: anxiety/depression with five
levels of severity:
(1) I am not anxious or depressed
(2) I am slightly anxious or depressed
(3) I am moderately anxious or depressed
(4) I am severely anxious or depressed
(5) I am extremely anxious or depressed
Five dimensions: (4) Happiness, 4 items (contentment, enthusiasm,
degree of feeling happiness, pleasure); (5) Coping, 3 items
(energy, being in control, coping with problems); (6)
Relationships, 7 items (relationship with family and friends,
social isolation, social exclusion, intimate relationship, family
role and community role); (7) Self-worth, 3 items (feeling like a
burden, worthlessness, confidence); (8) Mental Health, 8 items
(feelings of depression, trouble sleeping, feelings of anger, self-
harm, feeling despair, worry, sadness, tranquillity/agitation)
Super dimensions of
physical and
psychosocial health
No super dimensions Two super dimensions: Physical super dimension (PSD) and
Psychosocial super dimension (MSD). PSD includes independent
living, senses, and pain; MSD includes happiness, coping,
relationships, self-worth, and mental health
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Coping, Self-worth, Relationships, and Mental Health).
The AQoL-8D describes billions of health states and takes
5 min to complete [40, 41].
Participants were asked to self-complete both instru-
ments’ questionnaires before their bariatric surgery at the
pre-admission preoperative clinics and at two postoperative
reportable time points, namely 3 months and 1 year after
their bariatric surgery. Postoperative questionnaires were
mailed out for self-completion with an explanatory cover
letter and reply paid envelope enclosed. We evaluated the
EQ-5D-5L and AQoL-8D questionnaire completion by
assessing the overall proportion of participants who com-
pleted the questionnaire(s) at the study’s three time points
for whom an individual utility value could be generated
(outlined in Sect. 2.2).
2.2 Data Analysis
Participants with patient-reported HRQoL assessments for
one or both instruments, for at least one time point where
the MAUI algorithm (either instrument) could generate the
instrument’s utility valuations or scores were included in
the analyses (Table 2).
Baseline socio-demographic and clinical data were
analysed descriptively as mean [standard deviation (SD)]
for continuous variables and frequency (%) for categorical
variables. BMI was calculated as weight (kg)/[height (m)]2.
Percentage total weight loss was calculated as weight loss
(kg)/initial weight (kg) 9 100, and percentage excess
weight loss was calculated as total weight loss/{initial
weight - [25 9 height (m)2]} 9 100. Height and weight
data were collected from medical records at the study’s
three time points.
Utility valuations were generated for the EQ-5D-5L
using the most recent UK value based on directly elicited
preferences [33, 34] (range -0.281 to 1.00 utility points)
and for the AQoL-8D using the most recent Australian
scoring algorithm available on the AQoL group’s website
(http://www.aqol.com.au) (range ?0.09 to 1.0 utility
points). Summary statistics of both MAUIs’ utility valua-
tions and EQ-VAS were assessed as mean (SD) and median
(IQR), and for individual and super dimension scores
(AQoL-8D), they were assessed as mean (SD).
A minimal clinically important difference or minimal
important difference is the smallest difference in score in
the outcome of interest which patients perceive as benefi-
cial and which would mandate a change in the patient’s
management [46, 47]. A recently reported composite
minimal important difference for the EQ-5D-5L of selected
chronic health conditions including hypertension, heart
disease, arthritis, asthma or chronic obstructive pulmonary
disease, cancer, diabetes, chronic back pain, and anxiety or
depression has been calculated as 0.04 utility points [35].
We adopted this recent EQ-5D-5L composite measure for
our study because of the array of complex physical and
psychosocial health conditions included in the measure of
minimal important difference. There is no reported mini-
mal important difference for the AQoL-8D; however, there
is a reported minimal important difference for the AQoL-
4D. This is a composite measure that also includes chronic
health conditions [37]. We therefore conservatively
reported a minimal important difference for the AQoL-8D
as the upper bound of the confidence interval (CI) of the
AQoL-4D’s minimal important difference (95% CI
0.03–0.08), namely, 0.08 points [37].
AQoL-8D Australian population norms for the total
population and the 45- to 54-year-old age group were
sourced from recently derived and published norms for the
instrument [48].
Given that the MAUI-generated data are not normally
distributed and also the relatively small sample size, this
study employed the Wilcoxon signed rank test to test for
statistical significance at the 5% level (p B 0.05). The
Wilcoxon signed rank test for significance is the non-
parametric counterpart of the paired t test, and corresponds
to a test of whether the median of the differences between
paired observations is zero in the population from which
the sample is drawn [49].
We undertook sensitivity analyses on the subgroup of
individuals who fully completed both MAUIs’ question-
naires for all three reported time points (called ‘full-com-
pleters’) to test the robustness of all results including
significance testing.
Statistical analyses were undertaken using IBM SPPS
(version 22) or R (version 3.0.2).
3 Results
3.1 Participants’ Clinical and Socio-demographic
Characteristics and Questionnaire Completion
Twenty-three participants were recruited to the study and
completed at least one of the MAUIs’ questionnaires at one
of the reportable time points to enable the generation of
utility valuations (both instruments) and individual and
super dimension scores (AQoL-8D only) (Table 2).
For these participants (n = 23), mean (SD) age was 50
(10) years, 43% were males, and mean (SD) time on the
public waiting list for bariatric surgery was 6.5 (2.0) years.
Table 2 (supported by Appendix) also provides results
regarding changes in BMI, percentage total weight lost,
and percentage excess weight lost. At 1 year postopera-
tively, the percentage of total weight lost was mean (SD)
16% (7.1%). BMI decreased from mean (SD) 49.3 (9.3) kg/
m2 before surgery to 43.5 (7.2) (3 months) to 40.8 (7.0)
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(1 year) after surgery, giving rise to a significant reduction
of 8.5 BMI units preoperatively to 1 year postoperatively
(p = 0.02).
Appendix provides the socio-demographic characteristics
of all participants (n = 23), the subgroup of full-completers of
both questionnaires at all three reportable time points (n = 9),
and the subgroup of participants who did not fully complete all
questionnaires at the three reportable time points (n = 14).
There was no substantial difference in age or sex [all partici-
pants (n = 23) males 43%; full-completers (n = 9) males
44%; partial-completers (n = 14) males 42%]. The order of
magnitude for the number of years on the public waiting list
was also similar. The postoperative obesity classifications and
mean (SD) BMI measures were similar between the sub-
groups, and the magnitudes of change between obesity clas-
sifications were also similar between the subgroups.
Questionnaire completion for the entire cohort across
the three reported time points is outlined in detail in
Table 2. Overall, utility valuations could be assessed for
75% of participants for both MAUIs, and for individual and
super dimension scores for the AQoL-8D only. Subgroup
analyses were conducted for full-completers of both
instruments’ questionnaires across all three time points
(n = 9) (outlined below and Tables 2 and 3).
3.2 Changes in Both Instruments’ Utility Valuations
Compared to BMI
Table 2 provides summary results for changes in BMI,
utility valuations (both instruments), and EQ-VAS scores
at the three reported time points. Figure 1 also provides a
schematic representation of utility changes for the entire
cohort (n = 23) and full-completers (n = 9). Figure 2
provides the distribution of utility valuations at the indi-
vidual level for both instruments (Fig. 2a EQ-5D-5L and
Fig. 2b AQoL-8D) 1 year after surgery.
Our study’s key finding was that change in both instru-
ments’ summary utility valuations and also the EQ-VAS
scores reported clinical improvements that exceeded the
minimal important difference for all participants (n = 23)
(EQ-5D-5L 0.08 utility points; AQoL-8D 0.16 utility points;
EQ-VAS 16 points) from before surgery to 1 year after sur-
gery. Importantly, the change in utility valuations derived for
the AQoL-8D was twice that for the EQ-5D-5L (0.16 vs. 0.08
utility points) for the 1-year time horizon. Further, the AQoL-
8D utility change from baseline to 1 year was statistically
significant (p = 0.04), whereas only a trend was observed for
the EQ-5D-5L (p = 0.25) (Table 2; Fig. 1). When we com-
pared preoperative versus 1-year postoperative utility
increases to BMI reductions over the same time horizon, we
found that for every 1.0-unit reduction in BMI, the AQoL-8D
utility valuation increased 0.02 units, compared with a 0.01
increase in utility for the EQ-5D-5L.
Another important finding was that from 3 months to
1 year postoperatively, the mean EQ-5D-5L utility valua-
tion showed a slight decrease, by 0.02 utility points,
whereas the mean AQoL-8D utility valuation gave rise to
the third of the identified increases in utility for this
instrument across the three time points (?0.06 utility
points). An increase was also observed in the EQ-VAS
scores from 3 months to 1 year. Notwithstanding these
general trends, all changes from the reported 3 months to
1 year time point were not statistically significant
(Table 2).
After surgery utility valuations at the individual level for
both instruments were not normally distributed and the
AQoL-8D revealed a wider dispersion (Fig. 2).
Subgroup analyses revealed that the orders of magni-
tudes, general trends, and significance testing of all our
findings were robust when only the full-completers (n = 9)
were analysed (Tables 2, 3). For example, from before
surgery to 1 year after surgery, we found that the AQoL-
8D’s improvement in utility score 1 year after surgery was
0.15 points and the BMI reduction was 8.0 BMI units as
compared with 0.16 utility points and a BMI reduction of
8.5 BMI units for the entire cohort (Tables 2, 3).
3.3 Assessment of Individual Domains of HRQoL:
AQoL-8D Individual and Super Dimension
Scores
Table 3 provides a comparison of the AQoL-8D’s indi-
vidual dimensions (Independent Living, Senses, Pain,
Happiness, Coping, Self-worth, Relationships, and Mental
Health) and Physical and Psychosocial super dimensions
for the three reported time points, and subgroup analyses
and significance testing for the full-completers subgroup
from before surgery to 1 year after surgery.
A key finding for our particular study population of
long-term waitlisted patients a year after bariatric surgery
was that all individual and super dimension scores within
the AQoL-8D improved. The individual psychosocial
dimensions of Happiness, Coping, and Self-worth
improved the most over this time horizon (0.12, 0.12, and
0.10 point improvements, respectively). The individual
physical dimensions of Independent Living and Pain also
improved (0.10 and 0.11 points, respectively). Addition-
ally, Happiness and Coping approached general population
norms [48]. These results were robust to subgroup analysis
of full-completers of all three questionnaires (Table 3).
Importantly, significance testing of the full-completers’
results revealed that Happiness (p = 0.01), Coping
(p = 0.01), Self-worth (p = 0.03), and the Psychosocial
super dimension (p = 0.008), and the summary AQoL-8D
utility valuation (p = 0.01) were statistically significant
(Table 3).
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4 Discussion
Our exploratory study is the first study to investigate the
HRQoL impacts using both the EQ-5D-5L and AQoL-8D
for a study population of severely obese, long-term pub-
licly waitlisted patients who were then able to access bar-
iatric surgery in 2015 because of a 2014 State Government
public policy decision to reduce waiting times and to sur-
gically treat long-waiting patients.
We found that the participants’ responses to the EQ-5D-
5L and AQoL-8D generated clinical improvements in
utility valuations and EQ-VAS scores from before surgery
to 1 year after surgery, where the minimal important dif-
ferences were exceeded. Another important finding was
Table 2 Comparison of study participants’ (total participants, n = 23) BMI, summary health state utility valuations for the EQ-5D-5L and the
AQoL-8D, and EQ-VAS scores before and 3 months and 1 year after bariatric surgery, and sensitivity analyses for full completers (n = 9)
Before
surgery
3 months
after surgery
1 year after
surgery
Change in mean from 3 months to
1 year after surgery and ToS**
(p B 0.05)
Change in mean from before surgery
to 1 year after surgery and ToS**
(p B 0.05)
Years on public
waiting list,
mean (SD)
6.5 (2.0)
BMI (kg/m2)
Mean (SD)
(n = 21)
49.3 (9.3)*
(n = 21)
43.5 (7.2)
(n = 22)
40.8 (7.0)
-2.7 BMI points, p = 0.40 -8.5 BMI points, p = 0.02**
%TWL, mean
(SD)
NA NA 16% (7.1) NA 16%
%EWL, mean
(SD)
NA NA 34% (14.9) NA 34%
MAUIs’ HSUVs and EQ-VAS scores (n = x)
EQ-5D-5L (n = 16) (n = 19) (n = 18)
Mean (SD) 0.70 (0.25) 0.80 (0.25) 0.78 (0.25) -0.02 utility points, p = 0.92 ?0.08 utility points, p = 0.25
Median (IQR) 0.73
(0.54–0.91)
0.84
(0.59–0.86)
0.86
(0.67–0.93)
AQoL-8D (n = 15) (n = 18) (n = 17)
Mean (SD) 0.51 (0.24) 0.61 (0.24) 0.67 (0.23) ?0.06 utility points, p = 0.66 ?0.16 utility points, p = 0.04**
Median (IQR) 0.51
(0.29–0.78)
0.58
(0.43–0.78)
0.67
(0.48–0.86)
EQ-VAS (n = 16) (n = 19) (n = 18)
Mean (SD) 57 (25) 67 (24) 73 (19) ?6 points, p = 0.31 ?16 VAS score, p = 0.08
Median (IQR) 65 (34–73) 65 (48–90) 80 (56–90)
Subgroup analysis* (n = 9)
BMI (kg/m2),
mean (SD)
47.6 (7.4) 43.6 (6.1) 39.6 (6.4) 4.0 BMI points -8.0 BMI points
%TWL, mean
(SD)
NA NA 16.6% (7.3) NA 16.6%
%EWL, mean
(SD)
NA NA 36.3% (15.8) NA 36.3%
EQ-5D-5L
utility, mean
(SD)
0.69 (0.21) 0.80 (0.15) 0.73 (0.20) -0.07 utility points, p = 0.52 ?0.04 utility points, p = 0.26
AQoL-8D
utility, mean
(SD)
0.45 (0.19) 0.57 (0.21) 0.60 (0.22) ?0.03 utility points, p = 0.07 ?0.15 utility points, p = 0.01**
EQ-VAS, mean
(SD)
59 (22) 66 (22) 67 (21) ?1 VAS score ? 8 VAS score, p = 0.18
BMI body mass index, EWL excess weight lost, HSUV health state utility valuation, IQR interquartile range, MAUI multi-attribute utility
instrument, NA not applicable, SD standard deviation, ToS test of significance, TWL total weight lost, VAS visual analogue scale
 One long-term waitlisted patient’s time on the waiting list not available
* Full-completers subgroup analysis before and 3 months and 1 year after bariatric surgery
** ToS Wilcoxon rank test (p B 0.05)
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that the AQoL-8D’s increase in utility valuation (0.16
utility points) was twice that of the EQ-5D-5L increase
(0.08 utility points) at 1 year, with the AQoL-8D result
statistically significant (and robust to subgroup analyses of
the full-completers).
4.1 Public Resource Allocation to Bariatric
Surgery: Waiting Lists and Patient
Prioritisation
Our key findings highlighted two important and inextrica-
bly linked points regarding the assessment and utilisation
of utility valuations for long-term waitlisted patients who
subsequently undergo bariatric surgery. First, choice of an
appropriate MAUI to preferentially capture and assess
HRQoL for this study population is crucial. Second, sub-
optimal public resource allocation decisions regarding the
‘optimal’ amount of bariatric surgery will likely occur if
utility valuations, as an input measure of health impact for
health economic evaluation (specifically cost-utility anal-
yses), are generated by an instrument that is not sensitive to
this study population’s complex HRQoL.
Health economic evaluation is an important resource
allocation methodology because it provides decision-mak-
ers with comparable analyses to underpin decisions about
committing scarce healthcare resources to one use instead
of another [14]. Cost-utility analyses of bariatric surgery to
date have been dominated by use of the EQ-5D MAUIs
[14]. Economic evaluation of interventions which affect
HRQoL commonly employ cost-utility analyses which
prioritise interventions according to the cost per quality-
adjusted life-year. The estimation of quality-adjusted life-
years is increasingly based upon the utility valuations
predicted from an MAUI [50]. One of our study’s key
findings was that the AQoL-8D’s utility changes/impacts
from before surgery to 1 year after surgery were twice the
magnitude of the EQ-5D-5L. Additionally, the EQ-5D-5L
reported a plateauing utility valuation from 3 months to
1 year, in contrast to the AQoL-8D, which revealed a
clinical improvement. If the nominated instrument lacks
sensitivity within a particular health context (or health
domain), interventions (such as bariatric surgery) affecting
health states where the chosen instrument’s sensitivity is
low, will likely be disadvantaged [24, 50].
A recent study that investigated EQ-5D-5L utility val-
uations for patients who had undergone surgery at a
Canadian Bariatric Centre for Excellence (n = 304 before
surgery, n = 138 after surgery, 45% completion rate after
surgery) found that mean utility valuation before and
1 year after surgery was 0.65 (before)/0.90 (after) utility
points (for ‘other’ bariatric surgery) and 0.70 (before)/0.90
(after) utility points (for Roux-en-Y bariatric surgery) [51].
These results are similar to the order of magnitude of our
exploratory study’s EQ-5D-5L preoperative results. We
note that the higher postoperative valuation for the Cana-
dian study could be explained by the low completion rate,
arguably of patients who would rate themselves closer to
perfect health (45% of patients only responding 1 year
postoperatively), and the EQ-5D-5L’s inability to detect
health impacts closer to perfect health (ceiling effects).
Fig. 1 Comparison of the EQ-
5D-5L and AQoL-8D health
state utility valuations before
surgery and 3 months and
1 year after surgery
Long-Term Waitlisted Bariatric Surgery Patients’ Quality of Life Before and 1 Year After Surgery
In contrast, our study’s AQoL-8D preoperative sum-
mary utility valuations of mean (SD) 0.51 (0.24) indicated
a significantly diminished HRQoL for our study population
before surgery that was also reflected in the AQoL-8D’s
individual and super dimension scores. In turn, the AQoL-
8D’s ability to preferentially capture HRQoL (compared
with the EQ-5D-5L) for our study population of long-term
waitlisted patients who then subsequently underwent bar-
iatric surgery is reflected in the reduced utility valuations.
One of the key findings of our earlier research that con-
ducted a head-to-head comparison of the two instruments
was that the EQ-5D-5L and AQoL-8D are not inter-
changeable for people who had undergone bariatric surgery
many years previously [24]. This study of long-term
waitlisted patients also suggests that the AQoL-8D pref-
erentially captures HRQoL and that the two instruments are
not interchangeable for long-term waitlisted patients who
subsequently undergo bariatric surgery.
Recent evidence has found that utility valuations mea-
sured by the major MAUIs differ [namely, the EQ-5D-5L,
SF-6D, Health Utilities Index (HUI) 3, 15D and AQoL-8D]
[50]. Most of these differences can be explained by the
descriptive/classification systems of the MAUIs. These
‘dominating’ differences are estimated to explain an
average of 66% of the difference between utilities obtained
by the MAUIs (i.e. EQ-5D-5L, SF-6D, HUI 3, 15D, and
AQoL-8D) and 81% of the difference between the utilities
of the EQ-5D-5L and AQoL-8D [50]. In turn, our study’s
findings reflect the relative sensitivities of the EQ-5D-5L’s
and AQoL-8D’s classification systems to our study popu-
lation’s physical and psychosocial domains of health. The
AQoL-8D’s changes in utility valuation were predomi-
nantly driven by the AQoL-8D’s individual psychosocial
dimensions and Psychosocial super dimension scores.
The AQoL-8D’s utility valuations differed significantly
from before surgery to 1 year after surgery, predominantly
driven by the AQoL-8D’s individual psychosocial and
Psychosocial super dimension scores. Cost-utility analyses
of the health impacts for long-term waitlisted patients who
subsequently undergo bariatric surgery should appropri-
ately reflect these health impacts. Our findings are partic-
ularly important because cost-utility analyses of bariatric
surgery are dominated by the EQ-5D MAUIs [14].
In summary, long-term publicly waitlisted patients are an
important and emerging subgroup of bariatric surgery
patients, yet there is a paucity of evidence regarding longitu-
dinal HRQoL impacts for this population if they are successful
in getting publicly funded bariatric surgery. Our findings show
that previously long-waiting patients with substantially
diminished HRQoL did show significant improvements in
HRQoL after surgery. This is important in that it shows clearly
that long-waiting patients should not be ‘written off’—they
can still realise significant improvements in HRQoL outcome
when ultimately treated. A recent cost-utility study from
Sweden, the first study to quantify the potential impact of
extensive waiting times on the costs and clinical outcomes of
bariatric surgery, highlighted the necessity of reducing wait-
ing lists and removing unnecessary barriers to allow greater
utilisation of surgery for patients unresponsive to conservative
medical management [10]. Nevertheless, addressing this
issue, given the large gap between the demand for and supply
of publicly funded bariatric surgery, which has resulted in
protracted wait times for the procedure in countries such as
Australia, Canada, and the UK [17, 52] and the longest of any
surgical procedure in Canada (average 5 years) [17], would
require significant commitment and investment.
4.2 Weight Status is Only One Factor Contributing
to Complex HRQoL for Long-Term Waitlisted
Patients Who Undergo Bariatric Surgery
Another important finding of our study is that the AQoL-
8D’s individual and super dimension scores identify
Fig. 2 Frequency distributions of utility valuations at the individual
level for the EQ-5D-5L (n = 18) (a) and AQoL-8D (n = 17) (b) for
the entire cohort 1 year after bariatric surgery
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psychosocial health as an important driver of holistic
postoperative health 1 year after bariatric surgery. The
AQoL-8D’s Psychosocial super dimension almost doubled
in magnitude from before surgery to 1 year after surgery,
and this change was statistically significant. This result is
validated by a recent systematic review of the literature
regarding the quality-of-life outcomes of bariatric surgery,
where the SF-36 was the most commonly used HRQoL
instrument and the quality-of-life subscale for mental
health showed improvements in three of the six included
SF-36 studies [25]. Notably, none of these studies gener-
ated utility valuations or scores. Our study’s AQoL-8D
Psychosocial super dimension result is also validated by
recent literature which suggests that psychosocial health
status increases up to 4 years after bariatric surgery, but
declines after this timeframe [22, 23].
Utility valuations have also been found to be indepen-
dent predictors of health impacts [44]. Our study’s results
also support our earlier findings that if the choice of MAUI
appropriately captures the individual and study popula-
tion’s physical and psychosocial health status through the
sensitivity of the MAUI’s dimensions/classification system,
then the MAUI’s predictive qualities could be a useful
clinical measurement tool to rapidly and conveniently
assess the intervention’s likely health impacts in individ-
uals and for the study population [24].
Our study also found that relative to BMI unit reduc-
tions, the AQoL-8D recorded 0.02-utility point increases
for 1.0-BMI unit reductions, and for the EQ-5D-5L, 0.01-
utility point increases for 1.0-BMI unit reductions. A recent
study found that for the EQ-5D-3L, for a 1.0-unit BMI
reduction there was a 0.0051–0.0075 increase in utility.
Notwithstanding the differing classification systems and
utility valuations of the two MAUIs, the AQoL-8D recor-
ded a greater utility increase per unit of BMI reduction. We
contend that this difference was driven by the impact of
psychosocial health—the AQoL-8D’s broader (depth and
breadth) psychosocial classification system captured and
assessed domains of health that are not ‘weight change’ or
‘BMI change’ related. Our findings are also supported by a
recent cross-sectional study that compared quality of life
measured by the Moorehead–Ardelt Quality of Life
Questionnaire in obese patients 12–18 months after bar-
iatric surgery that found there is a limited relationship
between BMI and HRQoL [42].
In summary, we contend that the importance of psy-
chosocial factors in driving the measured improvements in
HRQoL should not be lost on policy-makers in allocating
resources. Much recent debate on bariatric surgery has
focused on the physical health impacts of weight loss,
especially on its potential to avoid or mitigate the worst
effects of diabetes. However, if much of the real health
gain observed derives from psychosocial impacts, this may
have important consequences for patient selection and
prioritisation decisions.
4.3 Increased Mobility
We also found that the AQoL-8D’s individual physical
dimensions of Independent Living and Pain improved from
before surgery to 1 year after surgery. A recent study that
conducted proportional analysis for the EQ-5D-5L has
found that mobility significantly increases 1 year after
bariatric surgery [51]. The increases in the AQoL-8D
individual physical dimensions of health and the Physical
super dimension further support these findings.
Only 10 of the 35 items of the AQoL-8D capture and
assess the physical domains of health that inform the
individual physical dimensions of Independent Living,
Senses, and Pain. A recent study suggests that the AQoL-
8D’s descriptive system is preferential to psychosocial
health rather than physical health [53].
4.4 Supporting Qualitative Evidence
Some of our study’s participants participated in long
interviews for an associated qualitative study regarding the
support needs of patients waiting for publicly funded bar-
iatric surgery [18]. The findings of this study indicated that
waiting for bariatric surgery was commonly associated
with a range of deleterious consequences including weight
gain and deteriorating physical and psychosocial health
[18]. These qualitative findings both support and provide
further contextualisation and nuance to our study’s baseline
AQoL-8D utility valuations and individual and Psychoso-
cial and Physical super dimension scores that revealed
substantially reduced summary utility valuations and
scores that were well below the relative Australian popu-
lation norms (Table 3). Our study has shown that our
cohort’s HRQoL was substantially diminished before sur-
gery, and this qualitative evidence also suggests it is likely
that utility valuations and individual and super dimension
scores could have been measurably lower for our unique
cohort if long-waiting patients were left untreated.
4.5 Limitations
There are a number of limitations to our study. The first
limitation is sample size. Nevertheless, our study was
exploratory and we were provided with a novel oppor-
tunity to recruit participants from the long-term wait-
listed patients subsequently fast-tracked for bariatric
surgery through a government policy decision to reduce
waiting lists. The second limitation is that all partici-
pants were operated on by the same surgeon in the same
hospital. This could affect the generalisability of our
Long-Term Waitlisted Bariatric Surgery Patients’ Quality of Life Before and 1 Year After Surgery
results if scaled up to all bariatric surgery patients. The
third limitation is that there is no control arm in the
study. The observational nature of our study did not
enable the recruitment of a control arm to elicit utility
valuations. The fourth limitation is the use of the UK
value set for the EQ-5D-5L because there is no Aus-
tralian value set available for the instrument. The final
limitation is that the sample is at risk of participant
selection bias, which could also affect the generalis-
ability of our results. Recent evidence has found that
public sector waiting times are years in duration in some
countries and that there are physical (worsening of
comorbidities and further weight gain) and psychosocial
impacts for patients waiting for bariatric surgery.
A strength of our study is the high response rate of 75%
to the questionnaires across all three reportable time
points. Additionally, our study is an exploratory study of
long-term waitlisted patients and could inform larger
confirmatory studies of HRQoL (particularly assessed
through utilities derived from generic MAUIs) for long-
term waitlisted patients who subsequently undergo bar-
iatric surgery.
5 Conclusions
Our exploratory study of long-term waitlisted patients
recruited opportunistically following a government policy
decision to reduce waiting lists suggests that long-waiting
bariatric surgery patients should not be ‘written off’ by
healthcare planners; they can still realise significant
improvements in HRQoL outcomes when ultimately trea-
ted, and this should be factored into patient prioritisation
decisions. Addressing this issue given the large gap
between the demand for and supply of publicly funded
bariatric surgery in many countries would require signifi-
cant commitment and investment.
Ongoing improvements in psychosocial parameters from
3 months to a year post-surgery explained improvements in
overall utility valuation measured by the AQoL-8D that
were not detected by EQ-5D-5L. Selection of a sensitive
instrument is crucial to adequately measure changes in
utility valuation and to accurately reflect changes in qual-
ity-adjusted life-years generated for cost-utility analyses.
Cost-utility analyses for long-term waitlisted patients for
bariatric surgery should employ utility valuations from
MAUIs that are sensitive to physical and psychosocial
health changes. Only through comprehensive assessments
of HRQoL impacts before and after surgery can we
robustly inform public resource allocation decisions. We
found that the AQoL-8D preferentially captures these
health impacts compared with the EQ-5D-5L.
Coupled with BMI assessment, pre-surgery utility val-
uations should be investigated as independent predictors of
post-surgery HRQoL (particularly psychosocial health
status) for morbidly obese, long-term waitlisted, bariatric
surgery patients.
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Appendix
Participants’ clinical and socio-demographic characteris-
tics before and 1 year after surgery for the total fast-track
cohort, the subgroup of participants who fully completed
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both MAUIs at all three time points, and the subgroup of
participants who were not full-completers (n = 14)
Characteristics Fast-track
cohort
(n = 23)
Full-
completers
(n = 9)
Partial
completers
(n = 14)
Age years, mean (SD) 50 (10) 48 (11) 52 (9)
Sex (n = x, %) Male (10,
43%)
Female (13,
57%)
Male (4,
44%)
Female (5,
56%)
Male (6,
42%)
Female (8,
58%)
Number of years on
public waiting list,
mean (SD)
6.5 (2.0)** 7.3 (2.5) 6.1 (1.6)
Number of participants in obesity category (n = x, %)
Before surgery
BMI C 30–34.9 kg/
m2 (Class I)
(1, 4%) 0 (1, 7%)
BMI C 35–39.9 kg/m2
(Class II)
0 0 0
BMI C 40–49.9 kg/
m2 (Class III)
(13, 57%) (7, 78%) (6, 43%)
BMI C 50 kg/m2 * (9, 39%) (2, 11%) (7, 50%)
12 months after surgery
BMI C30–34.9 kg/
m2 (Class I)
(2, 10%) (2, 14%) (3, 21%)
BMI C35–39.9 kg/
m2 (Class II)
(7, 33%) (3, 21%) (2, 14%)
BMI C40–49.9 kg/
m2 (Class III)
(9, 43%) (3, 21%) (6, 43%)
BMI C50 kg/m2 (3, 14%) (1, 11%) (2, 14%)
BMI (kg/m2)
Before surgery, mean
(SD)
49.3 (9.35) 47.6 (7.4) 49.9 (10.6)
After surgery, mean
(SD)
40.8 (7.0) 39.6 (6.4) 41.6 (7.5)
% Total weight lost,
mean (SD)
16 (7.1) NA NA
MAUI multi-attribute utility instrument, SD standard deviation, NA
not applicable
* Super-obese [54]
** One long-term waitlisted patient’s time on the waiting list not
available
 One missing value
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